Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Valacyclovir Augmentation for Cognitive and Functional Remediation in Schizophrenia

NCT01794897 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.

NCT NCT01794897
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01794897 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Valacyclovir Augmentation for Cognitive and Functional Remediation in Schizophrenia
Lead sponsor
University of Pittsburgh
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2013
Completion date
September 30, 2016
Enrollment
134 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

herpes simplex, schizoaffective disorder, schizophrenia